search
close
Departments
If you are considering conducting a clinical trial at our hospital, please follow the procedures outlined below in the "Procedures for Requesting a Clinical Trial."
The clinical trial office is located within the Pharmacy Department. If you have any questions, please contact us at the address below.
CRC operations are outsourced to a Study Management Organization (SMO). Please contact the clinical trial office for details about the outsourced organization.
| Department name | Target diseases |
|---|---|
| Digestive Center | Prevention of liver cancer recurrence, symptomatic gastroesophageal reflux disease, liver cirrhosis, Crohn's disease, hepatocellular carcinoma undergoing hepatic arterial embolization chemotherapy, ulcerative colitis, chronic hepatitis C, hepatic edema, prevention of gastric ulcer recurrence, reflux esophagitis, esophageal cancer, functional dyspepsia, pancreatic cancer, infectious enteritis, gastric cancer, gastric or colon resection |
| Heart Center | Congestive heart failure, atrial fibrillation, chronic heart failure, cardiac edema, acute pulmonary embolism (PE), ACS, pulmonary hypertension, previous myocardial infarction, deep vein thrombosis (DVT) |
| Respiratory Center | Chronic obstructive pulmonary disease, bronchial asthma, influenza, lung cancer |
| Nephrology | Rapidly progressive glomerulonephritis, diabetic nephropathy, IgA nephropathy, chronic kidney disease, microscopic polyangiitis, hyperphosphatemia, lupus nephritis, renal anemia |
| Diabetes/Endocrinology | Type 2 diabetes, type 1 diabetes, acromegaly, diabetic neuropathy |
| Neurology | Parkinson's disease, acute cerebral infarction, cerebral infarction, osteoporosis, prevention of recurrent cerebral infarction, prevention of recurrent stroke, myasthenia gravis, Alzheimer's disease, multiple sclerosis, spinocerebellar degeneration, Guillain-Barré syndrome |
| Neuropsychiatry | Social phobia (social anxiety disorder), Alzheimer's disease |
| breast surgery | breast cancer |
| Neurosurgery | Glioma (anaplastic astrocytoma, glioblastoma), trigeminal neuralgia |
| orthopedic surgery | Rheumatoid arthritis, knee osteoarthritis, prevention of venous thromboembolism, osteoporosis, lower back pain, patients undergoing TKA, patients undergoing THA |
| Urology | Interstitial cystitis, non-bacterial chronic prostatitis, urinary problems |
| Obstetrics and Gynecology | Osteoporosis, endometriosis |
| ophthalmology | Glaucoma, ocular hypertension, medical device clinical trials, cataracts, diabetic macular edema, retinitis pigmentosa, symptomatic vitreomacular adhesion |
| dermatology | infectious disease |
| Radiology | metastatic brain tumors |
| Anesthesiology | Patients undergoing upper extremity surgery |
| Pediatrics | enuresis |
| Rheumatology and Collagen Diseases | Rheumatoid arthritis, systemic lupus erythematosus (SLE) |
| Hematology | Eosinophilia, paroxysmal nocturnal hemoglobinuria, multiple myeloma |
| Pediatric Surgery | Pediatric hepatic encephalopathy |
New Request
Consult with the responsible physician
Secretariat hearing
Agree with the responsible physician
IRB
contract
Clinical trial drug delivery
Startup Meeting
Clinical trial begins
We do not distribute documents or forms, so please download them for use.
In principle, the event is held on the first Tuesday of every month. The deadline for submitting documents is two weeks before the event.
| Institutional Review Board meeting date 《First Tuesday of every month》 |
Deadline for submission of documents <2 weeks before the event> |
|
|---|---|---|
| 2026 | January 6th (Tuesday) | December 16th (Tuesday) |
| February 3rd (Tuesday) | January 20th (Tuesday) | |
| March 3 (Tuesday) | February 17th (Tuesday) | |
| April 7th (Tuesday) | Monday, March 24th | |
| May 12th (Tuesday)*2 | April 21 (Tue)*1 | |
| June 2 (Tuesday) | May 19th (Tuesday) | |
| July 7th (Tuesday) | June 23 (Tuesday) | |
| August 4th (Tuesday) | July 21 (Tuesday) | |
| September 1st (Tuesday) | August 18th (Tuesday) | |
| Tuesday, October 6th | September 15th (Tuesday)*1 | |
| November 10th (Tuesday)*2 | October 27th (Tuesday) | |
| December 1st (Tuesday) | November 17th (Tuesday) | |
| 2027 | January 5th (Tuesday) | December 15th (Tuesday)*1 |
| February 2 (Tuesday) | January 19th (Tuesday) | |
| March 2 (Tuesday) | February 16th (Tuesday) | |
CRC operations are outsourced to a clinical trial management organization (SMO).
Please follow the "Procedures for Post-Marketing Surveillance" below.
Kitano Medical Research Institute, Public Interest Incorporated Foundation, Tatsunokofukai
Clinical Trial Office
TEL 06-6131-2853
Email kitano-chiken@kitano-hp.or.jp
